Claus Frisenberg Pedersen

Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.

Liplasome Pharma ApS operates as a biotech company focusing on oncology. It develops drug delivery technologies for anticancer market. The firm's drug delivery platform consists of a lipid based drug delivery system for the intravenous transportation of anticancer drugs and prodrugs. The company was founded in 2002 and is headquartered in Hoersholm, Denmark.

ECCO Holding A/S invests in company with interest in designing, developing, and manufacturing of footwear products. The company was founded by Karl-Heinz Werner Toosbuy on June 7, 1997 and is headquartered in Bredebro, Denmark.

Loscam Australia Pty Ltd. operates timber mills and provides forklifts and rental equipment services. It offers plastic pallets, IBCs, Gpaks, and retail-ready merchandising units. It provides services such as pooling models, industry pooling, cross border, quality assurance, mange and support, services and depots. The company was founded in 1942 and is headquartered in Box Hill, Australia.

StormGeo AS provides decision support solutions and services for weather-sensitive operations. It serves customers in industries such as offshore oil, gas, renewable energy, media and shipping. The company was founded by Siri Margrethe Kalvig and Erik Langaker in 1997 and is headquartered in Bergen, Norway.

OW Bunker & Trading A/S offers a full range of fuel management services including risk management, technical guidance, logistics assistance and more. Their global trading division has traders positioned at all major hubs and key ports across the globe. In addition, OW's own physical supplies in locations worldwide, specialized refueling ships and tanker trucks, give them fast access and customer a reliable supply when and where customers need it.

Wrist Ship Supply A/S provides shipping and offshore services. Its products include provision and deck, engine, electrical, cabin, and bonded stores. The firm also engages in handling of owners goods, airfreight, and other marine services. The company was founded by Ove Wrist on June 15, 1953 and is headquartered in Norresundby, Denmark.

The European Union Chamber of Commerce is an organization with over 1,700 members in seven chapters operating in nine cities in China. The Chamber is based in Beijing, China, and was founded by Tom Sten Behrens-Sørensen. The organization provides advocacy, business intelligence, and community services to its members. The organization's website provides information on membership, events, publications, and policy focus. The Chamber aims to improve market access and operating conditions for European companies in China.

Dansk Erhverv is a business organization and employer association representing one of the world's most powerful business communities. The private company is based in Copenhagen, Denmark, and has subsidiaries in Denmark. With a membership of 18,000 companies and over 100 industry associations, the organization works daily to promote Denmark as the best country in the world to do business. The Danish company was founded by Tom Sten Behrens-Sørensen.

Wrist Ship Supply Holding A/S invests in companies with interest in offshore provisions and stores. It offers handling of goods, shipping, air freight, and marine services. The company was founded on June 15, 2012 and is headquartered in Norresundby, Denmark.

OW Bunker A/S operates as a marine fuel supplier. It serves container operators, bulk and tank operators, passenger and cruise lines, the off-shore industry, other suppliers and resellers through reselling and physical distribution models. The company was founded in 1980 and is headquartered in Norresundby, Denmark.

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

Part of Anpartsselskabet af 1. Oktober 2011, Ecco Tannery (Xiamen) Co. Ltd. engages in tanning leather products.

Part of Anpartsselskabet af 1. Oktober 2011, ECCO (Xiamen) Co. Ltd. is a leader in innovative comfort footwear for men, women, and kids. The Chinese company offers a wide range of shoes and footwear for women, including golf shoes of premium quality. Customers can enjoy free shipping and returns for members, and the current season is included in their markdowns. Founded in 1963, ECCO has a passion for creating great shoes and has come a long way since its foundation.

Red Sea Gateway Terminal Co. Ltd. provides cargo handling, port fees, and information services. The private company is based in Jeddah, Saudi Arabia. The Saudi Arabian company was founded in 2009. Jens O. Floe has been the CEO of the company since 2016.

Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell.

Iampatient AB develops a mobile application that assists patients with chronic diseases in managing their medication. The private company is based in Lund, Sweden. The Swedish company was founded by Lars Olof Hedbys.

Smile Incubator AB is a non-profit business incubator that focuses on helping life science entrepreneurs to commercialize their innovations. Smile Incubator is based in Lund, SE. The Swedish company's main goal is to enable better health through the development of new technologies and products. Ebba Cecilia FÃ¥hraeus has been the CEO of the private company since 2015.

Asgard Therapeutics AB engages in biotechnological research and development activities. It is in use of cellular reprogramming in cancer immunotherapy, which forces cancer cells to present their own antigens to the immune system, triggering expansion of cancer cell-specific killer T cells and cancer elimination. The company was founded by Filipe Pereira, Cristiana Pires and Fábio Rosa in 2018 and is headquartered in Lund, Sweden.

Odense Maritime Technology A/S operates as a management and consulting Danish company.

CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden.

Cell Invent Sweden AB is a company based in Lund, Sweden that develops new human disease models based on reprogrammed Alzheimer patient cells. The Swedish company is developing phenotype-based screening methods for drug discovery, drug development, and companion diagnostics development. The company was founded in 2019 by Håkan Toresson, Camilla Orbjörn, Lennart Minthon, Oskar Hansson, and Håkan Toresson has been the CEO since 2019.

Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions.